These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16954535)

  • 21. Yeast prion-protein, sup35, fibril formation proceeds by addition and substraction of oligomers.
    Narayanan S; Walter S; Reif B
    Chembiochem; 2006 May; 7(5):757-65. PubMed ID: 16570324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Increased tRNA concentration in yeast containing mutant termination translation factors eRF1 and eRF3].
    Zhuravleva GA; Moskalenko SE; Shabel'skaia SV; Philippe M; Inge-Vechtomov SG
    Mol Biol (Mosk); 2006; 40(4):724-30. PubMed ID: 16913231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of efficiency of translation termination in Saccharomyces cerevisiae.
    Nizhnikov AA; Antonets KS; Inge-Vechtomov SG; Derkatch IL
    Prion; 2014; 8(3):247-60. PubMed ID: 25486049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genome-wide translational changes induced by the prion [PSI+].
    Baudin-Baillieu A; Legendre R; Kuchly C; Hatin I; Demais S; Mestdagh C; Gautheret D; Namy O
    Cell Rep; 2014 Jul; 8(2):439-48. PubMed ID: 25043188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phenotypic manifestation of epigenetic determinant [ISP+] in Saccharomyces serevisiae depends on combination of mutations in SUP35 and SUP45 genes].
    Aksenova AIu; Volkov KV; Rovinskiĭ NS; Svitin AV; Mironova LN
    Mol Biol (Mosk); 2006; 40(5):844-9. PubMed ID: 17086985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An efficient protein transformation protocol for introducing prions into yeast.
    Tanaka M; Weissman JS
    Methods Enzymol; 2006; 412():185-200. PubMed ID: 17046659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetics in the extreme: prions and the inheritance of environmentally acquired traits.
    Halfmann R; Lindquist S
    Science; 2010 Oct; 330(6004):629-32. PubMed ID: 21030648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate threading through the central pore of the Hsp104 chaperone as a common mechanism for protein disaggregation and prion propagation.
    Tessarz P; Mogk A; Bukau B
    Mol Microbiol; 2008 Apr; 68(1):87-97. PubMed ID: 18312264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the [PSI+] prion on rates of adaptation in yeast.
    Joseph SB; Kirkpatrick M
    J Evol Biol; 2008 May; 21(3):773-80. PubMed ID: 18312560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal extension of Saccharomyces cerevisiae translation termination factor eRF3 influences the suppression efficiency of sup35 mutations.
    Volkov K; Osipov K; Valouev I; Inge-Vechtomov S; Mironova L
    FEMS Yeast Res; 2007 May; 7(3):357-65. PubMed ID: 17302942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structural basis of yeast prion strain variants.
    Toyama BH; Kelly MJ; Gross JD; Weissman JS
    Nature; 2007 Sep; 449(7159):233-7. PubMed ID: 17767153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased -1 ribosomal frameshifting efficiency by yeast prion-like phenotype [PSI+].
    Park HJ; Park SJ; Oh DB; Lee S; Kim YG
    FEBS Lett; 2009 Feb; 583(4):665-9. PubMed ID: 19166852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HAL3-PPZ1 dependent regulation of nonsense suppression efficiency in yeast and its influence on manifestation of the yeast prion-like determinant [ISP(+)].
    Aksenova A; Muñoz I; Volkov K; Ariño J; Mironova L
    Genes Cells; 2007 Apr; 12(4):435-45. PubMed ID: 17397392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [PSI(+)] turns 50.
    Tuite MF; Staniforth GL; Cox BS
    Prion; 2015; 9(5):318-32. PubMed ID: 26645632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The influence of mutations at ATG triplets of the open reading frame SUP35 on viability of the yeast Saccharomyces cerevisiae].
    Riabinkova NA; Borkhsenius AS; Inge-Vechtomov SG
    Genetika; 2009 Feb; 45(2):178-84. PubMed ID: 19334611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of NMD increases viability of sup45 nonsense mutants in Saccharomyces cerevisiae.
    Chabelskaya S; Gryzina V; Moskalenko S; Le Goff C; Zhouravleva G
    BMC Mol Biol; 2007 Aug; 8():71. PubMed ID: 17705828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion: disease or relief?
    Chernoff YO
    Nat Cell Biol; 2008 Sep; 10(9):1019-21. PubMed ID: 18758490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insights into the mechanism of prion propagation.
    Perrett S; Jones GW
    Curr Opin Struct Biol; 2008 Feb; 18(1):52-9. PubMed ID: 18243685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation of drugs active against mammalian prions using a yeast-based screening assay.
    Bach S; Talarek N; Andrieu T; Vierfond JM; Mettey Y; Galons H; Dormont D; Meijer L; Cullin C; Blondel M
    Nat Biotechnol; 2003 Sep; 21(9):1075-81. PubMed ID: 12910243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Estimating of changes in the amyloid and prion content of yeast cells].
    Nevzgliadova OV; Kuznetsova IM; Artemov AV; Mikhaĭlova EV; Turoverov KK; Soĭdla TR
    Tsitologiia; 2008; 50(1):40-8. PubMed ID: 18409367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.